Suppr超能文献

波多黎各登革热的经济成本。

Economic cost of dengue in Puerto Rico.

出版信息

Am J Trop Med Hyg. 2012 May;86(5):745-752. doi: 10.4269/ajtmh.2012.11-0784.

Abstract

Dengue, endemic in Puerto Rico, reached a record high in 2010. To inform policy makers, we derived annual economic cost. We assessed direct and indirect costs of hospitalized and ambulatory dengue illness in 2010 dollars through surveillance data and interviews with 100 laboratory-confirmed dengue patients treated in 2008-2010. We corrected for underreporting by using setting-specific expansion factors. Work absenteeism because of a dengue episode exceeded the absenteeism for an episode of influenza or acute otitis media. From 2002 to 2010, the aggregate annual cost of dengue illness averaged $38.7 million, of which 70% was for adults (age 15+ years). Hospitalized patients accounted for 63% of the cost of dengue illness, and fatal cases represented an additional 17%. Households funded 48% of dengue illness cost, the government funded 24%, insurance funded 22%, and employers funded 7%. Including dengue surveillance and vector control activities, the overall annual cost of dengue was $46.45 million ($12.47 per capita).

摘要

登革热在波多黎各流行,2010 年达到历史最高水平。为了给决策者提供信息,我们计算了每年的经济成本。我们通过监测数据和对 2008-2010 年期间 100 名经实验室确诊的登革热患者的访谈,评估了 2010 年美元计价的住院和门诊登革热疾病的直接和间接成本。我们使用特定环境的扩展因素来纠正漏报。由于登革热发作而导致的旷工超过了流感或急性中耳炎发作的旷工。从 2002 年到 2010 年,登革热疾病的年均总成本为 3870 万美元,其中 70%为成年人(15 岁以上)。住院患者占登革热疾病费用的 63%,死亡病例占 17%。家庭承担了 48%的登革热疾病费用,政府承担了 24%,保险承担了 22%,雇主承担了 7%。包括登革热监测和病媒控制活动在内,登革热的总年度成本为 4645 万美元(人均 12.47 美元)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87da/3335675/64f29d9f8c29/tropmed-86-745-g001.jpg

相似文献

1
Economic cost of dengue in Puerto Rico.
Am J Trop Med Hyg. 2012 May;86(5):745-752. doi: 10.4269/ajtmh.2012.11-0784.
2
Economic and disease burden of dengue in Mexico.
PLoS Negl Trop Dis. 2015 Mar 18;9(3):e0003547. doi: 10.1371/journal.pntd.0003547. eCollection 2015 Mar.
3
Economic cost and burden of dengue in the Philippines.
Am J Trop Med Hyg. 2015 Feb;92(2):360-366. doi: 10.4269/ajtmh.14-0139. Epub 2014 Dec 15.
5
Household and Hospitalization Costs of Pediatric Dengue Illness in Colombo, Sri Lanka.
Am J Trop Med Hyg. 2021 May 17;105(1):110-116. doi: 10.4269/ajtmh.20-1179.
7
Epidemic dengue fever in Puerto Rico, 1977: a cost analysis.
Am J Trop Med Hyg. 1979 Nov;28(6):1040-4. doi: 10.4269/ajtmh.1979.28.1040.
8
Guidelines on the cost-effectiveness of larval control programs to reduce dengue transmission in Puerto Rico.
Rev Panam Salud Publica. 2003 Jul;14(1):9-16. doi: 10.1590/s1020-49892003000600003.
9
Economic and disease burden of dengue illness in India.
Am J Trop Med Hyg. 2014 Dec;91(6):1235-1242. doi: 10.4269/ajtmh.14-0002. Epub 2014 Oct 6.

引用本文的文献

1
Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand.
PLoS Med. 2025 Jun 17;22(6):e1004631. doi: 10.1371/journal.pmed.1004631. eCollection 2025 Jun.
3
Integrated One Health strategies in Dengue.
One Health. 2024 Jan 28;18:100684. doi: 10.1016/j.onehlt.2024.100684. eCollection 2024 Jun.
4
Perceptions of dengue risk and acceptability of a dengue vaccine in residents of Puerto Rico.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2323264. doi: 10.1080/21645515.2024.2323264. Epub 2024 Apr 10.
5
Host immunity and vaccine development against Dengue virus.
Infect Med (Beijing). 2022 Feb 6;1(1):50-58. doi: 10.1016/j.imj.2021.12.003. eCollection 2022 Mar.
6
Economic impact of dengue in Singapore from 2010 to 2020 and the cost-effectiveness of Wolbachia interventions.
PLOS Glob Public Health. 2021 Oct 13;1(10):e0000024. doi: 10.1371/journal.pgph.0000024. eCollection 2021.
7
8
Economic burden estimation associated with dengue and chikungunya in Gujarat, India.
J Family Med Prim Care. 2022 Sep;11(9):5393-5403. doi: 10.4103/jfmpc.jfmpc_694_21. Epub 2022 Oct 14.
10
Do disease epidemics force economic activity underground? International evidence.
Contemp Econ Policy. 2022 Apr;40(2):263-282. doi: 10.1111/coep.12557. Epub 2021 Oct 26.

本文引用的文献

1
Emerging vector-borne flavivirus diseases: are vaccines the solution?
Expert Rev Vaccines. 2011 May;10(5):563-5. doi: 10.1586/erv.11.35.
2
Health economics of dengue: a systematic literature review and expert panel's assessment.
Am J Trop Med Hyg. 2011 Mar;84(3):473-88. doi: 10.4269/ajtmh.2011.10-0521.
3
Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development.
Curr Infect Dis Rep. 2010 May;12(3):157-64. doi: 10.1007/s11908-010-0102-7.
4
Dengue: a continuing global threat.
Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S7-16. doi: 10.1038/nrmicro2460.
5
Update on the global spread of dengue.
Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S40-2. doi: 10.1016/j.ijantimicag.2010.06.018. Epub 2010 Sep 15.
6
Dengue.
Br Med Bull. 2010;95:161-73. doi: 10.1093/bmb/ldq019. Epub 2010 Jul 8.
8
Dengue infection: a growing global health threat.
Biosci Trends. 2007 Oct;1(2):90-6.
9
Progress towards a dengue vaccine.
Lancet Infect Dis. 2009 Nov;9(11):678-87. doi: 10.1016/S1473-3099(09)70254-3.
10
Dengue is a major global health problem. Foreword.
J Clin Virol. 2009 Oct;46 Suppl 2:S1-2. doi: 10.1016/S1386-6532(09)70285-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验